DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / A•••••• T••••••••• I•••
A•••••• T••••••••• I•••
Stage unknownNew York, NYBiotechnology
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 rounds
- Feb 27, 2024Form D equity offering · $100.0M (form d sold) · 31 investorsFact SEC EDGAR Form D data sets (quarterly) · “A•••••• T••••••••• I••• filed Form D: $99,997,998 sold of $99,997,998, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
5 officers, 4 directors
- A••• H•••••• Chief Commercial Officer sec.gov
- C•••••••• T••••• Chief Accounting Officer sec.gov
- L•• F••••••••• Chief Financial Officer and Director sec.gov
- R••••••• P••••••• Chief Medical Officer sec.gov
- S••••••• S••••••••• President and Chief Executive Officer sec.gov
- S•••• J• K••••• Director Fact
- J••• S• M••••• Director Fact
- T•••• J• L••••• Director Fact
- J•• S• S••••• Director Fact
Timeline
1
- Mar 13, 2024A•••••• T••••••••• I••• filed Form D: $99,997,998 sold of $99,997,998, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $100.0M Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $100.0M Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-02-27 Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 31 Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity,option Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY, 10017 Mar 13, 2024 Fact SEC EDGAR Form D data sets (quarterly)